SEC Form 4 · accession 0001209191-18-047522
Xencor Inc · XNCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul A Foster
Officer — Chief Medical Officer
Period of report
Aug 17, 2018
Accepted (ET)
Aug 17, 2018 · 6:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326732
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 17, 2018 | M | 3,659 | $11.05 | A | 8,611 | D | |
| Common Stock | Aug 17, 2018 | S | 3,659 | $40.10 | D | 4,952 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $11.05 | Aug 17, 2018 | M | 3,659 | D | — | Feb 20, 2024 | Common Stock | 3,659 | 50,000 | D |
Explanation of responses
- F1The stock option is fully vested.